structure of N-allyl-4-oxo-3,4-dihydrophthalazine-1-carboxamide

N-allyl-4-oxo-3,4-dihydrophthalazine-1-carboxamide

CAS No.: 99989-14-7
M. Wt: 229.23
M. Fa: C12H11N3O2
InChI Key: RHZKAEYCYUEAML-UHFFFAOYSA-N

Names and Identifiers of 99989-14-7

CAS Number

99989-14-7

MDL Number

MFCD03197328

IUPAC Name

4-oxo-N-prop-2-enyl-3H-phthalazine-1-carboxamide

InChI

InChI=1S/C12H11N3O2/c1-2-7-13-12(17)10-8-5-3-4-6-9(8)11(16)15-14-10/h2-6H,1,7H2,(H,13,17)(H,15,16)

InChIKey

RHZKAEYCYUEAML-UHFFFAOYSA-N

Canonical SMILES

C=CCNC(=O)C1=NNC(=O)C2=CC=CC=C21

UNSPSC Code

12352100

Physical and chemical properties of 99989-14-7

Molecular Formula

C12H11N3O2

Molecular Weight

229.23

Safety Information of 99989-14-7

Pictograms

Signal Word

 Warning

Safety Data Sheet
Supports customized editing of SDS information and downloading in PDF documents.

Applications of 99989-14-7

N-allyl-4-oxo-3,4-dihydrophthalazine-1-carboxamide has potential applications in various fields:

  • Pharmaceutical Development: Due to its biological activity, it may serve as a lead compound in drug discovery targeting infectious diseases or cancer.
  • Agricultural Chemicals: Its antimicrobial properties could be explored for use in agricultural fungicides or bactericides.

Interaction Studies of 99989-14-7

Interaction studies are crucial for understanding the pharmacokinetics and pharmacodynamics of N-allyl-4-oxo-3,4-dihydrophthalazine-1-carboxamide. Initial findings suggest:

  • Binding Affinity: Investigations into its binding affinity with various biological targets (e.g., enzymes or receptors) are necessary to elucidate its mechanism of action.
  • Synergistic Effects: Combining this compound with other antimicrobial agents may enhance its efficacy against resistant strains.

Biological Activity of 99989-14-7

Preliminary studies indicate that N-allyl-4-oxo-3,4-dihydrophthalazine-1-carboxamide exhibits potential biological activities. It has been noted for its:

  • Antimicrobial Properties: The compound shows effectiveness against certain bacterial strains, making it a candidate for further pharmacological development.
  • Anticancer Activity: Some derivatives of phthalazine compounds have been associated with anticancer effects, suggesting that N-allyl derivatives may also possess similar properties.